10x Genomics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value
10x Genomics, Inc. (TXG) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value of $19.31 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue · last filed 2026-08-07
- 10x Genomics, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for the quarter ending 2026-03-31 was $19.14, a 50.26% decline year-over-year.
- 10x Genomics, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for the quarter ending 2025-03-31 was $38.48, a 16.93% decline year-over-year.
- 10x Genomics, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for the quarter ending 2024-03-31 was $46.32, a 22.55% decline year-over-year.
- 10x Genomics, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for the quarter ending 2023-03-31 was $59.81, a 49.44% decline year-over-year.
- 10x Genomics, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for fiscal 2025 was $27.12, a 34.37% decline from fiscal 2024.
- 10x Genomics, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for fiscal 2024 was $41.32, a 24.07% decline from fiscal 2023.
- 10x Genomics, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for fiscal 2023 was $54.42, a 41.38% decline from fiscal 2022.
- 10x Genomics, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for fiscal 2022 was $92.83, a 24.66% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value 12 month |
|---|---|---|---|---|
| 2026-06-30 | $19.31 10-Q · filed 2026-08-07 | |||
| 2026-03-31 | $19.14 10-Q · filed 2026-05-08 | |||
| 2025-12-31 | $27.12 10-K · filed 2026-02-13 | |||
| 2025-09-30 | $28.24 10-Q · filed 2025-11-07 | |||
| 2025-06-30 | $30.52 10-Q · filed 2025-08-08 | |||
| 2025-03-31 | $38.48 10-Q · filed 2025-05-09 | |||
| 2024-12-31 | $41.32 10-K · filed 2025-02-13 | |||
| 2024-09-30 | $42.01 10-Q · filed 2024-10-29 | |||
| 2024-06-30 | $46.89 10-Q · filed 2024-08-08 | |||
| 2024-03-31 | $46.32 10-Q · filed 2024-04-30 | |||
| 2023-12-31 | $54.42 10-K · filed 2024-02-15 | |||
| 2023-09-30 | $54.79 10-Q · filed 2023-11-03 | |||
| 2023-06-30 | $57.69 10-Q · filed 2023-08-04 | |||
| 2023-03-31 | $59.81 10-Q · filed 2023-05-04 | |||
| 2022-12-31 | $92.83 10-K · filed 2023-02-16 | |||
| 2022-09-30 | $105.49 10-Q · filed 2022-11-03 | |||
| 2022-06-30 | $113.63 10-Q · filed 2022-08-09 | |||
| 2022-03-31 | $118.30 10-Q · filed 2022-05-05 | |||
| 2021-12-31 | $123.21 10-K · filed 2022-02-18 | |||
| 2021-09-30 | $118.67 10-Q · filed 2021-11-05 | |||
| 2021-06-30 | $108.34 10-Q · filed 2021-08-06 | |||
| 2021-03-31 | $86.44 10-Q · filed 2021-05-07 | |||
| 2020-12-31 | $66.71 10-K · filed 2021-02-26 | |||
| 2020-09-30 | $64.97 10-Q · filed 2020-11-12 | |||
| 2020-06-30 | $64.32 10-Q · filed 2020-08-12 |